Market Size, Share, and Growth Outlook of Omalizumab Biosimilars
The landscape of allergy and immunology treatment is shifting as the Omalizumab Monoclonal Antibody Biosimilars Market expands. Biologics have transformed care for chronic allergic diseases, but high costs often limit access for many patients worldwide. Biosimilars are poised to change this by offering comparable clinical benefits at reduced costs. Strategic alliances between biopharma...
0 Comments 0 Shares 134 Views 0 Reviews